Skip to Main content Skip to Navigation
Journal articles

Gene therapy in monogenic congenital myopathies

Abstract : Current treatment options for patients with monogenetic congenital myopathies (MCM) ameliorate the symptoms of the disorder without resolving the underlying cause. However, gene therapies are being developed where the mutated or deficient gene target is replaced. Preclinical findings in animal models appear promising, as illustrated by gene replacement for X-linked myotubular myopathy (XLMTM) in canine and murine models. Prospective applications and approaches to gene replacement therapy, using these disorders as examples, are discussed in this review.
Document type :
Journal articles
Complete list of metadata
Contributor : Melissa Goddard <>
Submitted on : Thursday, July 11, 2019 - 11:48:34 AM
Last modification on : Saturday, July 3, 2021 - 12:16:51 AM

Links full text



Xuan Guan, Melissa Goddard, David Mack, Martin Childers. Gene therapy in monogenic congenital myopathies. Methods, Elsevier, 2016, 99, pp.91-98. ⟨10.1016/j.ymeth.2015.10.004⟩. ⟨hal-02180076⟩



Record views